相关实验视频

Updated: Sep 19, 2025

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

Published on: October 22, 2019

在囊性纤维化中,ENaC有助于巨细胞功能障碍

John Moran¹, Courtney Pugh², Nevian Brown²

¹Center for Cystic Fibrosis and Airways Disease Research (CF-AIR), Emory University, Atlanta, Georgia, United States.

American journal of physiology. Lung cellular and molecular physiology

|June 2, 2025

概括

皮质通道 (ENaC) 在囊性纤维化 (CF) 免疫细胞中过度表达,损害了它们的功能. 在CF巨细胞中抑制ENaC可以恢复正常的免疫反应,并可能为CF感染控制提供新的治疗策略.

科学领域:

免疫学免疫学免疫学
细胞生物学细胞生物学
呼吸系统医学呼吸系统医学

背景情况:

囊性纤维化 (CF) 涉及功能障碍的囊性纤维化跨膜导电调节器 (CFTR).
CFTR调节先天免疫力,但其他离子通道在CF免疫功能障碍中的作用尚不清楚.
皮质通道 (ENaC) 与CF气道上皮细胞功能障碍有关.

研究的目的:

调查假设ENaC在CF巨细胞中异常表达,并损害免疫功能.
探索ENaC调制作为CF感染和炎症的潜在治疗点.

主要方法:

从CF和非CF捐赠者的免疫细胞中特征性的ENaC表达.
评估单细胞衍生巨细胞 (MDM) 功能和通过ENaC调制杀死细菌.
在实验中使用CFTR抑制和CFTR调节器治疗.

主要成果:

在CF MDM,淋巴细胞和粒细胞中增加了ENaC表达 (转录和蛋白质).
在CFMDM中抑制ENaC使活性氧物种 (ROS) 生产正常化,改善了自,并减少了促炎细胞因子.
ENaC抑制增加了CFTR表达,而CFTR调节器治疗部分减少了ENaC过度表达.

结论:

在CF免疫细胞中异常的ENaC表达有助于细胞和炎症功能受损.
ENaC调制为CF感染控制提供了一个新的治疗点,可能补充或取代CFTR调制剂.

关键词:

囊性纤维化症是什么免疫力是一种免疫力.离子通道离子通道巨细胞是一个巨细胞.细胞是一种细胞.

更多相关视频

Assessing Anti-fungal Activity of Isolated Alveolar Macrophages by Confocal Microscopy

Assessing Anti-fungal Activity of Isolated Alveolar Macrophages by Confocal Microscopy

Published on: July 9, 2014

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

相关概念视频

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...